SOCIETY: AGA Risk stratification and screening of Barrett's esophagus: What's new?

Presentations:

IN BARRETT'S ESOPHAGUS, REFLUX INDUCES FEATURES OF EPITHELIAL-MESENCHYMAL PLASTICITY MEDIATED BY APE/REF-1 REDOX FUNCTION: EVIDENCE FROM STUDIES IN BARRETT'S PATIENTS AND ORGANOIDS

BEYOND TFF3: IDENTIFYING NON-ENDOSCOPIC DNA METHYLATION BIOMARKERS FOR IMPROVED DIAGNOSIS OF BARRETT'S ESOPHAGUS

VALIDATION OF RISK ASSESSMENT TOOLS FOR THE DETECTION OF BARRETT’S ESOPHAGUS IN PATIENTS WITHOUT CHRONIC REFLUX SYMPTOMS

UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION

NONENDOSCOPIC DETECTION OF BARRETT'S ESOPHAGUS IN PATIENTS WITHOUT GERD SYMPTOMS

DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT’S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET)

John Spak

Appearances